# SSgA SPDR ETFs Europe II Plc - S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD (GXLV)

**Source:** https://fundology.uk/fund/gxlv · ISIN IE00BWBXM617 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 01/10/2026, GXLV (S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD, ISIN IE00BWBXM617) closed at £39.45 on the London Stock Exchange. Its ongoing charge is 0.15% a year (about £15 on £10,000). Over the five years to 01/10/2026 its total return was +21.4%, or −5.1% after UK CPIH inflation.

## Summary

SSgA SPDR ETFs Europe II Plc - S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD is an exchange-traded fund (ETF) from SPDR, launched in 2015. It tracks the S&P Health Care Select Sector Daily Capped 35/20 Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.15% a year — about £15 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£39.45** (01/10/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | GXLV |
| ISIN | IE00BWBXM617 |
| Category | Healthcare |
| Type | ETF |
| Provider | SPDR |
| Tracks | S&P Health Care Select Sector Daily Capped 35/20 Index |
| Income | Accumulating |
| Ongoing charge | 0.15% a year (£15 per £10,000) |
| Fund size | £321m |
| Launched | 2015 |
| Domicile | Ireland |

## Past returns (periods to 01/10/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +5.53% | +2.21% | income reinvested |
| 3 years | +18.17% | +6.63% | income reinvested |
| 5 years | +21.43% | -5.08% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Charges compared with similar funds

Ongoing charge of SSgA SPDR ETFs Europe II Plc - S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD 0.15% a year, as of 01/10/2026: 14 of the 17 other healthcare funds charge more, 1 the same and 2 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.15%** per year
- ISA eligible: yes
- SIPP eligible: yes

## Top holdings

Largest positions (as of 30/09/2026):

| Holding | Weight |
|---|---|
| Eli Lilly and | 15.17% |
| Johnson & Johnson | 10.45% |
| AbbVie | 7.57% |
| Merck | 5.87% |
| UnitedHealth Group | 5.40% |
| Thermo Fisher Scientific | 4.09% |
| Amgen | 3.73% |
| Gilead Sciences | 3.03% |
| Abbott Laboratories | 2.80% |
| Pfizer | 2.66% |

All 60 holdings: https://fundology.uk/fund/gxlv/holdings

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.